Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183.

Laura E. de Vries, Patrick A. M. Jansen, Catalina Barcelo, Justin Munro, Julie M. J. Verhoef, Charisse Flerida A. Pasaje, Kelly Rubiano, Josefine Striepen, Nada Abla, Luuk Berning, Judith M. Bolscher, Claudia Demarta-Gatsi, Rob W. M. Henderson, Tonnie Huijs, Karin M J Koolen, Patrick K. Tumwebaze, Tomas Yeo, Anna C. C. Aguiar, Iñigo Angulo-Barturen, Alisje ChurchyardJake Baum, Benigno Crespo Fernández, Aline Fuchs, Francisco-Javier Gamo, Rafael V. C. Guido, María Belén Jiménez-Diaz, Dhelio B. Pereira, Rosemary Rochford, Camille Roesch, Laura M. Sanz, Graham Trevitt, Benoit Witkowski, Sergio Wittlin, Roland A. Cooper, Philip J. Rosenthal, Robert W. Sauerwein, Joost Schalkwijk, Pedro H. H. Hermkens, Roger V. Bonnert, Brice Campo, David A. Fidock, Manuel Llinás, Jacquin C. Niles, Taco W. A. Kooij, Koen J. Dechering

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalDefault journal
Volume13
DOIs
StatePublished - Apr 20 2022

Keywords

  • Animals
  • Antimalarials
  • Folic Acid Antagonists
  • Malaria
  • Falciparum
  • Vivax
  • Mice
  • Pantothenic Acid
  • Plasmodium falciparum
  • Rats

Disciplines

  • Parasitic Diseases

Cite this